Sign in

CIK 0001285819

  • Non-accelerated filer
  • Smaller reporting company

OMEROS CORP

Sign in to watch
Ticker
OMER
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
911663741
Phone
+1 206-676-5000
Business address
201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,837,566
in 4 filings, $626K under 10b5-1 plans

Net −$1,837,566. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 78 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-06-14 JACOBSEN MICHAEL A VP Finance and CAO Exercise or conversion +12,850 $9.37 $120K 12,850
2017-06-14 JACOBSEN MICHAEL A VP Finance and CAO Sale −9,350 $19.95 $187K 3,500
2017-06-14 JACOBSEN MICHAEL A VP Finance and CAO Exercise or conversion · Stock Option (Right to Buy) −12,850 88,000
2017-06-13 JACOBSEN MICHAEL A VP Finance and CAO Exercise or conversion +2,650 $9.37 $25K 2,650
2017-06-13 JACOBSEN MICHAEL A VP Finance and CAO Sale −2,650 $19.95 $53K 0
2017-06-13 JACOBSEN MICHAEL A VP Finance and CAO Exercise or conversion · Stock Option (Right to Buy) −2,650 100,850
2017-04-12 Cable Thomas J. Director Sale −3,000 $16.49 $49K 40,067
2017-03-20 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion +2,040 $6.05 $12K 168,641
2017-03-20 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion · Stock Option (Right to Buy) −2,040 11,000
2017-02-26 Demopulos Gregory A MD Chairman, CEO & President Grant or award · Stock Option (Right to Buy) +375,000 375,000
2017-02-26 Kelbon Marcia S. VP Patent and General Counsel Grant or award · Stock Option (Right to Buy) +75,000 75,000
2017-02-26 JACOBSEN MICHAEL A VP Finance and CAO Grant or award · Stock Option (Right to Buy) +70,000 70,000
2016-12-14 Cable Thomas J. Director Sale −3,000 $10.21 $31K 43,067
2016-12-07 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion +102,044 $0.98 $100K 1,987,029
2016-12-07 Demopulos Gregory A MD Chairman, CEO & President Sale −102,044 $10.48 $1.1M 1,884,985
2016-12-07 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion · Stock Option (Right to Buy) −102,044 0
2016-12-06 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion +102,040 $0.98 $100K 1,987,025
2016-12-06 Demopulos Gregory A MD Chairman, CEO & President Sale −102,040 $10.80 $1.1M 1,884,985
2016-12-06 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion · Stock Option (Right to Buy) −102,040 102,044
2016-12-05 JACOBSEN MICHAEL A VP Finance and CAO Grant or award · Stock Option (Right to Buy) +85,000 85,000

Page 15 of 20 · 391 trades